SunLink Capex To Revenue from 2010 to 2024

SSY Stock  USD 0.77  0.02  2.67%   
SunLink Health Capex To Revenue yearly trend continues to be fairly stable with very little volatility. Capex To Revenue will likely drop to 0.02 in 2024. Capex To Revenue is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. View All Fundamentals
 
Capex To Revenue  
First Reported
2010-12-31
Previous Quarter
0.04522195
Current Value
0.0238518
Quarterly Volatility
0.01970335
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check SunLink Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SunLink Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.5 M, Interest Expense of 855 or Total Revenue of 30.8 M, as well as many indicators such as Price To Sales Ratio of 0.17, Dividend Yield of 0.0 or PTB Ratio of 0.74. SunLink financial statements analysis is a perfect complement when working with SunLink Health Valuation or Volatility modules.
  
Check out the analysis of SunLink Health Correlation against competitors.

Latest SunLink Health's Capex To Revenue Growth Pattern

Below is the plot of the Capex To Revenue of SunLink Health Systems over the last few years. It is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. SunLink Health's Capex To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in SunLink Health's overall financial position and show how it may be relating to other accounts over time.
Capex To Revenue10 Years Trend
Pretty Stable
   Capex To Revenue   
       Timeline  

SunLink Capex To Revenue Regression Statistics

Arithmetic Mean0.04
Geometric Mean0.03
Coefficient Of Variation54.12
Mean Deviation0.02
Median0.03
Standard Deviation0.02
Sample Variance0.0004
Range0.0634
R-Value0.23
Mean Square Error0.0004
R-Squared0.05
Significance0.42
Slope0.001
Total Sum of Squares0.01

SunLink Capex To Revenue History

2024 0.0239
2023 0.0452
2022 0.0417
2021 0.0772
2020 0.0638
2019 0.0248
2018 0.0279

About SunLink Health Financial Statements

SunLink Health investors use historical fundamental indicators, such as SunLink Health's Capex To Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in SunLink Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capex To Revenue 0.05  0.02 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for SunLink Stock Analysis

When running SunLink Health's price analysis, check to measure SunLink Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SunLink Health is operating at the current time. Most of SunLink Health's value examination focuses on studying past and present price action to predict the probability of SunLink Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SunLink Health's price. Additionally, you may evaluate how the addition of SunLink Health to your portfolios can decrease your overall portfolio volatility.